Abstract

Aim and objective: To Categories women presenting with leiomyoma with respect to: • Age • Most common symptom • Location of leiomyoma. Settings and Design: This was an observational study carried out in a tertiary health center for a period of 1 year from September 2019 to September 2020. Materials and Methods: A retrospective observational study was conducted in 35 women having pain in abdomen, abnormal uterine bleeding, who were presented to the department of obstetric and gynecology, Bharati Vidyapeeth deemed university, Pune between sept 2019 and sept 2020. All the patient presented with above mentioned symptoms were studied after obtaining consent from participant. Ultrasound was done and location of leiomyoma was studied. Fibroid were studied in terms of its, location and most common presenting symptoms and age of occurrence of symptoms. Results: In our study, themost common age group of presentation was 36-40 years (reproductive age group.) Most common type of fibroid was intramural (62.8 %) Most common symptoms was menorrhagia (57.1%). Most commonly associated with nulligravida (49.5%).

• 1.   Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Human reproduction update. 2018 Jan 1;24(1):59-85.
• 2.   Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American journal of obstetrics and gynecology. 2003 Jan 1;188(1):100-7.
• 3.   Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406.
• 4.   Bukulmez O, Doody KJ. Clinical features of myomas. ObstetGynecol Clin North Am. 2006;33(1):69–84.
• 5.   Laughlin Tommaso SK, Hesley GK, Hopkins MR, Brandt KR, Zhu Y, Stewart EA. Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. International Journal of Gynecology& Obstetrics. 2017 Nov;139(2):143-8.
• 6.   Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and risk factors of uterine fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology. 2018 Jan 1;46:3-11.
• 7.   Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. American family physician. 2007 May 15;75(10):1503-8.
• 8.   Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J ObstetGynaecol Can. 2015;37(2):157–181.
• 9.   Carranza-Mamane B, Havelock J, Hemmings R, et al. The management of uterine fibroids in women with otherwise unexplained infertility. J ObstetGynaecol Can. 2015;37(3):277–288.
• 10.   Aarts JW, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;(8):CD003677.

Data Sharing Statement

Funding